Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients.

MLA

Cundy, K. C., et al. “Clinical Pharmacokinetics of Cidofovir in Human Immunodeficiency Virus-Infected Patients.” Antimicrobial Agents and Chemotherapy, vol. 39, no. 6, June 1995, pp. 1247–52. EBSCOhost, https://doi.org/10.1128/AAC.39.6.1247.

APA

Cundy, K. C., Petty, B. G., Flaherty, J., Fisher, P. E., Polis, M. A., Wachsman, M., Lietman, P. S., Lalezari, J. P., Hitchcock, M. J., & Jaffe, H. S. (1995). Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients. Antimicrobial Agents and Chemotherapy, 39(6), 1247–1252. https://doi.org/10.1128/AAC.39.6.1247

Chicago

Cundy, K C, B G Petty, J Flaherty, P E Fisher, M A Polis, M Wachsman, P S Lietman, J P Lalezari, M J Hitchcock, and H S Jaffe. 1995. “Clinical Pharmacokinetics of Cidofovir in Human Immunodeficiency Virus-Infected Patients.” Antimicrobial Agents and Chemotherapy 39 (6): 1247–52. doi:10.1128/AAC.39.6.1247.